AU4046072A - 6,9-oxygen bridged erythromycin derivatives - Google Patents

6,9-oxygen bridged erythromycin derivatives

Info

Publication number
AU4046072A
AU4046072A AU40460/72A AU4046072A AU4046072A AU 4046072 A AU4046072 A AU 4046072A AU 40460/72 A AU40460/72 A AU 40460/72A AU 4046072 A AU4046072 A AU 4046072A AU 4046072 A AU4046072 A AU 4046072A
Authority
AU
Australia
Prior art keywords
erythromycin derivatives
oxygen bridged
bridged erythromycin
oxygen
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU40460/72A
Inventor
Paul Kurath
Richard Stephan Egan
Peter Hadley Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to AU40460/72A priority Critical patent/AU4046072A/en
Publication of AU4046072A publication Critical patent/AU4046072A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
AU40460/72A 1972-03-27 1972-03-27 6,9-oxygen bridged erythromycin derivatives Expired AU4046072A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU40460/72A AU4046072A (en) 1972-03-27 1972-03-27 6,9-oxygen bridged erythromycin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU40460/72A AU4046072A (en) 1972-03-27 1972-03-27 6,9-oxygen bridged erythromycin derivatives

Publications (1)

Publication Number Publication Date
AU4046072A true AU4046072A (en) 1973-10-04

Family

ID=3727673

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40460/72A Expired AU4046072A (en) 1972-03-27 1972-03-27 6,9-oxygen bridged erythromycin derivatives

Country Status (1)

Country Link
AU (1) AU4046072A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU593006B2 (en) * 1985-08-31 1990-02-01 Kenkyusho, Kitasato Erythromycin derivative and process for preparing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU593006B2 (en) * 1985-08-31 1990-02-01 Kenkyusho, Kitasato Erythromycin derivative and process for preparing the same

Similar Documents

Publication Publication Date Title
ZA733143B (en) 2,1,3-benzothiadiazole derivatives
KE2670A (en) 1,2,3,-thiadiazole derivatives
MY7900243A (en) Substituted 16,17,18,19,20-pentanor-prostaglandins
CA1012534A (en) 2,6-diaminonebularine derivatives
ZA744364B (en) 4,3-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
GB1406961A (en) 2,4,7-trioxopteridine derivatives
GB1402046A (en) 11,12-epoxyerythromycins
JPS5745162A (en) Substituted 1,2,4,5-tetrahydro-3h,3-benzoazepines
HK15179A (en) 2,6-diaminoneburlarine derivatives
KE2864A (en) 1, 4-dithiino (2,3,-c) pyrrole derivatives
PH9479A (en) 2,4-diamond quinazoline derivative
AU4046072A (en) 6,9-oxygen bridged erythromycin derivatives
CA969176A (en) 6,9-oxygen bridged erythromycin derivatives
AU469505B2 (en) 1,4-ethano-2,3-dihydroquinoline derivatives
GB1404278A (en) 15,17a-unsubstituted-d-homosteroids
IL43666A0 (en) Substituted 9,10-dihydro-anthracenes
AU5759173A (en) 1,2,4-oxadiazole derivatives
GR63160B (en) 15a,16a-methyley-y-oistren-17b-olas
PH10500A (en) 7h-indolizino(5,6,7-ij)isoquinoline derivatives
ZA731789B (en) 2,3,5-substituted-6-trifluoromethyl-1,3-diazin-4-ones
ZA733182B (en) 10,11-anhydroerythromycins
IL39236A0 (en) 8-aza-(3,2,1)-bicyclooctan-3-ol derivatives
ZA735169B (en) 1,4-ethano-2,3-dihydroquinoline derivatives
GB1400789A (en) 1,1-azobis-benzimidazolium salts
ZA733990B (en) Beta(3,4-dialkanyloxyphenyl)-l-alanines